The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL Read more about The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Read more about A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis Read more about A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis
A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) Read more about A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia Read more about Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma Read more about Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease Read more about A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study Read more about The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL Read more about Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL